Specific breast cancer prognosis-subtype distinctions based on DNA methylation patterns. 2018

Shumei Zhang, and Yihan Wang, and Yue Gu, and Jiang Zhu, and Ce Ci, and Zhongfu Guo, and Chuangeng Chen, and Yanjun Wei, and Wenhua Lv, and Hongbo Liu, and Dongwei Zhang, and Yan Zhang
College of Bioinformatics Science and Technology, Harbin Medical University, China.

Tumour heterogeneity is an obstacle to effective breast cancer diagnosis and therapy. DNA methylation is an important regulator of gene expression, thus characterizing tumour heterogeneity by epigenetic features can be clinically informative. In this study, we explored specific prognosis-subtypes based on DNA methylation status using 669 breast cancers from the TCGA database. Nine subgroups were distinguished by consensus clustering using 3869 CpGs that significantly influenced survival. The specific DNA methylation patterns were reflected by different races, ages, tumour stages, receptor status, histological types, metastasis status and prognosis. Compared with the PAM50 subtypes, which use gene expression clustering, DNA methylation subtypes were more elaborate and classified the Basal-like subtype into two different prognosis-subgroups. Additionally, 1252 CpGs (corresponding to 888 genes) were identified as specific hyper/hypomethylation sites for each specific subgroup. Finally, a prognosis model based on Bayesian network classification was constructed and used to classify the test set into DNA methylation subgroups, which corresponded to the classification results of the train set. These specific classifications by DNA methylation can explain the heterogeneity of previous molecular subgroups in breast cancer and will help in the development of personalized treatments for the new specific subtypes.

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001499 Bayes Theorem A theorem in probability theory named for Thomas Bayes (1702-1761). In epidemiology, it is used to obtain the probability of disease in a group of people with some characteristic on the basis of the overall rate of that disease and of the likelihood of that characteristic in healthy and diseased individuals. The most familiar application is in clinical decision analysis where it is used for estimating the probability of a particular diagnosis given the appearance of some symptoms or test result. Bayesian Analysis,Bayesian Estimation,Bayesian Forecast,Bayesian Method,Bayesian Prediction,Analysis, Bayesian,Bayesian Approach,Approach, Bayesian,Approachs, Bayesian,Bayesian Approachs,Estimation, Bayesian,Forecast, Bayesian,Method, Bayesian,Prediction, Bayesian,Theorem, Bayes
D012372 ROC Curve A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli. ROC Analysis,Receiver Operating Characteristic,Analysis, ROC,Analyses, ROC,Characteristic, Receiver Operating,Characteristics, Receiver Operating,Curve, ROC,Curves, ROC,ROC Analyses,ROC Curves,Receiver Operating Characteristics
D016009 Chi-Square Distribution A distribution in which a variable is distributed like the sum of the squares of any given independent random variable, each of which has a normal distribution with mean of zero and variance of one. The chi-square test is a statistical test based on comparison of a test statistic to a chi-square distribution. The oldest of these tests are used to detect whether two or more population distributions differ from one another. Chi-Square Test,Chi Square Distribution,Chi Square Test,Chi-Square Distributions,Chi-Square Tests,Distribution, Chi-Square,Distributions, Chi-Square,Test, Chi-Square,Tests, Chi-Square
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses
D018899 CpG Islands Areas of increased density of the dinucleotide sequence cytosine--phosphate diester--guanine. They form stretches of DNA several hundred to several thousand base pairs long. In humans there are about 45,000 CpG islands, mostly found at the 5' ends of genes. They are unmethylated except for those on the inactive X chromosome and some associated with imprinted genes. CpG Clusters,CpG-Rich Islands,Cluster, CpG,Clusters, CpG,CpG Cluster,CpG Island,CpG Rich Islands,CpG-Rich Island,Island, CpG,Island, CpG-Rich,Islands, CpG,Islands, CpG-Rich

Related Publications

Shumei Zhang, and Yihan Wang, and Yue Gu, and Jiang Zhu, and Ce Ci, and Zhongfu Guo, and Chuangeng Chen, and Yanjun Wei, and Wenhua Lv, and Hongbo Liu, and Dongwei Zhang, and Yan Zhang
January 2019, Frontiers in genetics,
Shumei Zhang, and Yihan Wang, and Yue Gu, and Jiang Zhu, and Ce Ci, and Zhongfu Guo, and Chuangeng Chen, and Yanjun Wei, and Wenhua Lv, and Hongbo Liu, and Dongwei Zhang, and Yan Zhang
September 2020, Cancer gene therapy,
Shumei Zhang, and Yihan Wang, and Yue Gu, and Jiang Zhu, and Ce Ci, and Zhongfu Guo, and Chuangeng Chen, and Yanjun Wei, and Wenhua Lv, and Hongbo Liu, and Dongwei Zhang, and Yan Zhang
January 2023, Frontiers in genetics,
Shumei Zhang, and Yihan Wang, and Yue Gu, and Jiang Zhu, and Ce Ci, and Zhongfu Guo, and Chuangeng Chen, and Yanjun Wei, and Wenhua Lv, and Hongbo Liu, and Dongwei Zhang, and Yan Zhang
March 2021, Journal of cellular physiology,
Shumei Zhang, and Yihan Wang, and Yue Gu, and Jiang Zhu, and Ce Ci, and Zhongfu Guo, and Chuangeng Chen, and Yanjun Wei, and Wenhua Lv, and Hongbo Liu, and Dongwei Zhang, and Yan Zhang
February 2021, Medicine,
Shumei Zhang, and Yihan Wang, and Yue Gu, and Jiang Zhu, and Ce Ci, and Zhongfu Guo, and Chuangeng Chen, and Yanjun Wei, and Wenhua Lv, and Hongbo Liu, and Dongwei Zhang, and Yan Zhang
September 2010, PloS one,
Shumei Zhang, and Yihan Wang, and Yue Gu, and Jiang Zhu, and Ce Ci, and Zhongfu Guo, and Chuangeng Chen, and Yanjun Wei, and Wenhua Lv, and Hongbo Liu, and Dongwei Zhang, and Yan Zhang
January 2021, Cancer control : journal of the Moffitt Cancer Center,
Shumei Zhang, and Yihan Wang, and Yue Gu, and Jiang Zhu, and Ce Ci, and Zhongfu Guo, and Chuangeng Chen, and Yanjun Wei, and Wenhua Lv, and Hongbo Liu, and Dongwei Zhang, and Yan Zhang
May 2017, BMC medical genomics,
Shumei Zhang, and Yihan Wang, and Yue Gu, and Jiang Zhu, and Ce Ci, and Zhongfu Guo, and Chuangeng Chen, and Yanjun Wei, and Wenhua Lv, and Hongbo Liu, and Dongwei Zhang, and Yan Zhang
December 2016, BMC systems biology,
Shumei Zhang, and Yihan Wang, and Yue Gu, and Jiang Zhu, and Ce Ci, and Zhongfu Guo, and Chuangeng Chen, and Yanjun Wei, and Wenhua Lv, and Hongbo Liu, and Dongwei Zhang, and Yan Zhang
March 2020, Journal of cellular biochemistry,
Copied contents to your clipboard!